Correlation Between Decade Resources and Blueprint Medicines
Can any of the company-specific risk be diversified away by investing in both Decade Resources and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Decade Resources and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Decade Resources and Blueprint Medicines Corp, you can compare the effects of market volatilities on Decade Resources and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Decade Resources with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Decade Resources and Blueprint Medicines.
Diversification Opportunities for Decade Resources and Blueprint Medicines
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Decade and Blueprint is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Decade Resources and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and Decade Resources is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Decade Resources are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of Decade Resources i.e., Decade Resources and Blueprint Medicines go up and down completely randomly.
Pair Corralation between Decade Resources and Blueprint Medicines
Assuming the 90 days horizon Decade Resources is expected to generate 5.74 times more return on investment than Blueprint Medicines. However, Decade Resources is 5.74 times more volatile than Blueprint Medicines Corp. It trades about 0.04 of its potential returns per unit of risk. Blueprint Medicines Corp is currently generating about 0.06 per unit of risk. If you would invest 8.50 in Decade Resources on October 5, 2024 and sell it today you would lose (6.92) from holding Decade Resources or give up 81.41% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Decade Resources vs. Blueprint Medicines Corp
Performance |
Timeline |
Decade Resources |
Blueprint Medicines Corp |
Decade Resources and Blueprint Medicines Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Decade Resources and Blueprint Medicines
The main advantage of trading using opposite Decade Resources and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Decade Resources position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.Decade Resources vs. First American Silver | Decade Resources vs. Australian Vanadium Limited | Decade Resources vs. International Lithium Corp | Decade Resources vs. Wealth Minerals |
Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |